Sequential loss of myelin proteins during Wallerian degeneration in the human spinal cord

A Buss1, K Pech, D Merkler

  • 1Department of Neurology, Aachen University Medical School, Georg-August-Universität Gottingen, Germany. arminbuss@hotmail.com

Insights

In human CNS injuries, myelin proteins persist for years after axon loss, hindering regeneration. This study tracked myelin changes in post-mortem spinal cords, revealing delayed myelin sheath breakdown compared to animal models.

Area of Science:

  • Neuroscience
  • Pathology
  • Regenerative Medicine

Background:

  • Axons in the central nervous system (CNS) typically do not regenerate after injury, unlike in the peripheral nervous system (PNS).
  • Myelin-associated proteins (MAPs) are implicated in inhibiting CNS axonal regeneration.
  • Little is known about MAPs' role in human CNS pathologies and Wallerian degeneration (WD).

Purpose of the Study:

  • To investigate the temporal changes of four MAPs during WD in human post-mortem spinal cords.
  • To compare human WD timelines with those observed in animal models.
  • To understand the role of persistent MAPs in the hostile environment for CNS axon regeneration.

Main Methods:

  • Immunohistochemical analysis of post-mortem spinal cord tissue from 22 patients with cerebral infarction or traumatic spinal cord injury.
  • Assessment of temporal changes in four MAPs over periods ranging from 2 days to 30 years post-injury.
  • Correlation of MAP loss with axonal marker disappearance.

Main Results:

  • Human myelin sheath loss during WD is significantly delayed and occurs slowly over years, contrasting with rapid degeneration in rats.
  • A sequential loss of myelin proteins was observed, dependent on their location within the myelin sheath.
  • Proteins like NOGO-A persisted for over 3 years in degenerating tracts, long after axon loss.

Conclusions:

  • The delayed and slow breakdown of myelin sheaths in humans contributes to a prolonged inhibitory environment for CNS axon regeneration.
  • Persistent axon growth-inhibitory MAPs, such as NOGO-A, may impede functional recovery after human CNS injuries.
  • Findings emphasize the need to bridge the gap between animal research and human clinical pathology regarding CNS injury and regeneration.

Related Concept Videos

Nervous Tissue: Myelin01:25

Nervous Tissue: Myelin

The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...